Team identifies compound that could improve drug development against deadly brain cancer
A study led by scientists at the Translational Genomics Research Institute (TGen) has identified "a potent inhibitory compound" in the elusive hunt for an improved treatment against glioblastoma, the most common and deadly ...
Jan 17, 2017
0
6